Fundraising FoxWren Capital
Venture capitalLondon · Seed–Series A · 1 people tracked
Find your way into Wren Capital
Sign up to see every warm intro you have to Wren Capital
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Wren Capital team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Team · 1 people
from public directoriesWhat they invest in
from 7 of 8 portfolio companiesDeep Tech ×4Biotech ×3Hardware ×3Healthtech ×2Medical Devices ×2Semiconductors ×2AdTech ×1Advanced Manufacturing ×1
HQs:United Kingdom×4United States×1
Investments · 8 tracked
founders shown can be your intro pathBy year:2023 · 12016 · 12013 · 24 dated
Exonate is a biotechnology company developing treatments for retinal vascular diseases, with a lead asset (EXN407) intended as a topical therapy for diabetic retinopathy and diabetic macular oedema.
BiotechDigital HealthHealthtechMedical Devices
Olav Hellebø(Chief Executive Officer)in
Co-investorsO2h VenturesWellcome TrustCambridge Angels groupEMV CapitalMartlet CapitalStoic VC+1 more
Keit is a technology hardware company founded in 2013 as a spin-out from the Science and Technology Facilities Council and European Space Agency Business Incubation Centre, developing new technology for established industries.
Advanced ManufacturingDeep TechHardwareOxfordshire, GB
Co-investorsUK Innovation & Science Seed FundFuture Planet CapitalLongwall Venture Partners LLP
Blu Wireless develops millimeter wave radio networking technology for wireless communications.
Deep TechDefense TechHardwareSemiconductorsBristol, GB
Anthony Murray(Chief Executive Officer)inJohnny Bray(Chief Financial Officer)inDave Purle(Chief Operating Officer)Ciara Barron(Director of Marketing)inDarren McNamara(Director of Technology Development)inJonathan Rogers(Director of Systems and Platforms)in
Co-investorsMaven Capital PartnersCambridge Angels groupPerscitus LLPSalica InvestmentsARMCalculus Capital Ltd.+1 more
Bristol-based developer of mmWave wireless communication systems for defence, high-speed rail and other mobility markets.
Co-investorsCalculus Capital Ltd.Guinness VenturesPerscitus LLPARMCalculus
MitoRx develops first-in-class, targeted small-molecule therapies that restore mitochondrial health to treat people with high-risk, metabolically unhealthy obesity and related cardiometabolic diseases.
BiotechHealthtechLongevityHarwell Oxford, GB
Jon R.(Founder)inJon Rees PhD(Co-founder & Chief Executive Officer)Norman Law PhD(Co-founder, Chief Technology Officer & Head of Intellectual Property)
Co-investorsFuture Planet CapitalOxford Investment Opportunity Network (OION)Oxford Technology ManagementUK Innovation & Science Seed FundEmpirical Ventures
PharmEnable applies AI to small molecule drug discovery, focusing on challenging and data-sparse biological targets that traditional methods struggle to address.
AI & Machine LearningBiotechDeep Tech
Hannah Sore(Founder)in
Co-investorsCambridge Angels groupMartlet CapitalMC Healthcare VenturesDiamond Edge VenturesO2h VenturesParkwalk Advisors
Singular provides a marketing analytics platform that combines cost aggregation, mobile and cross-device attribution, fraud prevention, and creative analytics for marketing teams.
AdTechMarketing TechSaaSSan Francisco, US
Gadi Eliashiv(CEO & Co-founder)inSusan Kuo(COO & Co-founder)inEran Friedman(CTO & Co-founder)inNichael Oiknine(Executive Officer)Stephanie Pilon(CMO)inYoni Amias(CCO)in
Co-investorsMethod CapitalNorwest Venture PartnersTitanium VenturesTransLink CapitalGeneral CatalystZ Venture Capital+3 more
.png)
Singular Photonics develops digital image sensors based on single-photon avalanche diode (SPAD) technology, which convert photons directly into digital signals to capture depth and temporal data as 4D images.
Deep TechHardwareMedical DevicesSemiconductors
Co-investorsCambridge Angels groupQubits VenturesACF InvestorsOld College CapitalScottish Enterprise
Portfolio news
latest coverage across their companies
Singular Photonics · digit.fyi · Aug 19, 2026
MitoRx Therapeutics · globenewswire.com · Jun 9, 2026
Principals & officers · per Companies House
what is this? ⓘLLP designated member · since 2011
Rajat Malhotra — 25–50% of voting rights, significant influence or control limited liability partnership, right to share surplus assets 25 to 50 percent limited liability partnership
Richard Donald Cameron — 25–50% of voting rights, significant influence or control limited liability partnership, right to share surplus assets 25 to 50 percent limited liability partnership
Frequently asked questions
- How many investments has Wren Capital made?
- Wren Capital has 8 tracked investments.
- What stage does Wren Capital invest at?
- Wren Capital invests at the Seed, Series A stages.
- What sectors does Wren Capital focus on?
- Wren Capital focuses on Biotech, Healthtech, IoT, Medical Devices.
- Where is Wren Capital located?
- Wren Capital is headquartered in London, GB.
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Venrock is a venture capital firm investing across technology and healthcare, backing companies in fintech, developer infrastructure, life sciences, therapeutics, semiconductors, and consumer products.
Connecticut Innovations is the state of Connecticut's venture capital arm, providing financing and ongoing strategic support to innovative, growing companies based in Connecticut.
Elm Street Ventures is a seed and early-stage venture fund in New Haven, Connecticut that primarily backs companies with a Yale connection, especially technology developed at and licensed from Yale.
Ambix is a healthcare-focused investment firm that provides funding, strategy, and hands-on support to companies developing medical tools and devices, biochemistry-based technologies, digital health applications, and other novel healthcare solutions. It invests across all stages and also builds companies itself.